ArticlePLoS neglected tropical diseases2026
Rapid, label-free surface plasmon resonance discrimination between Bothrops and Crotalus venoms using clinical antivenom as the capture reagent.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Snake envenoming is recognized as a global health problem, affecting thousands of people every year. One of the main challenges in addressing this issue is the correct identification and treatment of these envenomations, particularly in locations where people do not have easy access to hospitals. In Brazil, the genus Bothrops is responsible for the majority of envenomations, followed by Crotalus. This study reports a simple methodology for detecting crude venom from snakes of the genus Bothrops, through interaction with their corresponding antibodies, using a high-sensitivity optical biosensor. The protocol consists of adding antibodies (present in the commercial antivenom) to the sensor surface, followed by the addition of Crotalus venom (nonspecific), and then Bothrops venom (specific), resulting in changes in the refractive index, to evaluate cross reactions between them. Different concentrations of raw venom from snakes of the genus Bothrops and Crotalus were tested, starting with a concentration of 6.784 [Formula: see text]gmL-1 and progressing until reaching the minimum detectable concentration. The binding capacity of venom to antivenom was investigated at two concentrations of antivenom: 5 [Formula: see text]gmL-1 and 50 [Formula: see text]gmL-1. Both antivenom and snake venoms were solubilized in phosphate-buffered saline (PBS). The results show an accurate detection of the antigen of interest (Bothrops venom), tested at different concentrations. The biosensor was able to detect venom up to a concentration of 0.848 [Formula: see text]gmL-1. In addition, no interference from nonspecific binding between the Bothrops antivenom and Crotalus venom was detected. The detection of specific venom (Bothrops) occurred in a satisfactory time (up to 14 minutes). The results provide evidence that the biosensor and the methodology employed can be considered a diagnostic model under development, which can help health workers to better identify and treat envenomated people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.